Acceleration of Fracture Healing in Experimental Model: Platelet-Rich Fibrin or Hyaluronic Acid?
暂无分享,去创建一个
[1] I. Ozcan,et al. Acceleration of Fracture Healing in Experimental Model: Platelet-Rich Fibrin or Hyaluronic Acid? , 2018, The Journal of craniofacial surgery.
[2] Xiu-hua Mao,et al. The efficacy and safety of platelet-rich fibrin for rotator cuff tears: a meta-analysis , 2018, Journal of Orthopaedic Surgery and Research.
[3] Zuoliang Qi,et al. Clinical Application of Platelet-Rich Fibrin in Plastic and Reconstructive Surgery: A Systematic Review , 2018, Aesthetic Plastic Surgery.
[4] Shannon W Finks,et al. Idarucizumab (Praxbind): The First Reversal Agent for a Direct Oral Anticoagulant. , 2017, The American journal of medicine.
[5] V. Jayaraman,et al. Direct oral anticoagulants compared with warfarin in patients with severe blunt trauma. , 2017, Injury.
[6] M. Shapiro,et al. Management of anticoagulation agents in trauma patients. , 2014, Clinics in laboratory medicine.
[7] A. Goss,et al. Protocol in managing oral surgical patients taking dabigatran , 2014, BDJ.
[8] E. Grove,et al. New oral anticoagulants: clinical indications, monitoring and treatment of acute bleeding complications , 2014, Acta anaesthesiologica Scandinavica.
[9] D. M. Dohan Ehrenfest,et al. Platelet-rich plasma (PRP) and Platelet-Rich Fibrin (PRF): surgical adjuvants, preparations for in situ regenerative medicine and tools for tissue engineering. , 2012, Current pharmaceutical biotechnology.
[10] D. Feder,et al. Warfarin: pharmacological profile and drug interactions with antidepressants. , 2012, Einstein.
[11] L. Jacobs. Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly. , 2008, Cardiology clinics.